scholarly journals MP354SYMMETRIC DIMETHYLARGININE, HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE

2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii556-iii557
Author(s):  
Stephen Zewinger ◽  
Marcus Kleber ◽  
Lucia Rohrer ◽  
Alexander Dressel ◽  
Hubert Scharnagl ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
High Density ◽  
High Density Lipoproteins

scholarly journals High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future

Biomedicines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 857
Author(s):  
Josep Julve ◽  
Joan Carles Escolà-Gil
Keyword(s):  
Cardiovascular Disease ◽  
High Density Lipoprotein ◽  
High Density Lipoprotein Cholesterol ◽  
Density Lipoprotein ◽  
Epidemiological Studies ◽  
High Density ◽  
High Density Lipoproteins ◽  
Atherosclerotic Cardiovascular Disease ◽  
Plasma High Density ◽  
Low Levels

Epidemiological studies have shown that low levels of plasma high-density lipoprotein cholesterol (HDL-C) are associated with increased atherosclerotic cardiovascular disease (CVD) [...]

High-density lipoproteins and cardiovascular disease: 2010 update

2010 ◽  
Vol 8 (3) ◽  
pp. 413-423 ◽  
Author(s):  
Khalid Alwaili ◽  
Zuhier Awan ◽  
Ali Alshahrani ◽  
Jacques Genest
Keyword(s):  
Cardiovascular Disease ◽  
High Density ◽  
High Density Lipoproteins

Antibodies to high-density lipoproteins are associated with inflammation and cardiovascular disease in rheumatoid arthritis patients

2015 ◽  
Vol 166 (6) ◽  
pp. 529-539 ◽  
Author(s):  
Javier Rodríguez-Carrio ◽  
Mercedes Alperi-López ◽  
Patricia López ◽  
Francisco J. Ballina-García ◽  
Francisco Abal ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cardiovascular Disease ◽  
High Density ◽  
High Density Lipoproteins

HIV-related cardiovascular disease: any role for high-density lipoproteins?

2020 ◽  
Vol 319 (6) ◽  
pp. H1221-H1226
Author(s):  
Peter Hudson ◽  
Nicholas J. Woudberg ◽  
Festus Kamau ◽  
Hans Strijdom ◽  
Miguel A. Frias ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Structural Changes ◽  
Density Lipoprotein ◽  
High Density ◽  
Noncommunicable Diseases ◽  
High Density Lipoproteins ◽  
Atherosclerotic Cardiovascular Disease ◽  
Early Biomarkers ◽  
Increased Risk ◽  
Immunodeficiency Virus

The introduction of antiretroviral therapy (ART) has improved the life expectancy of patients infected with human immunodeficiency virus (HIV). However, this population is at an increased risk for noncommunicable diseases, including atherosclerotic cardiovascular disease (CVD). Both ART and viral infection may be potential contributors to the pathophysiology of HIV-related CVD. The mechanisms behind this remain unclear, but it is critical to delineate early biomarkers of cardiovascular risk in the HIV population. In this review, we postulate that potential biomarkers could include alterations to high-density lipoprotein (HDL). Indeed, recent data suggest that HIV and ART may induce structural changes of HDL, thus resulting in shifts in HDL subclass distribution and HDL functionality.

scholarly journals Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease

2017 ◽  
Vol 38 (20) ◽  
pp. 1597-1607 ◽  
Author(s):  
Stephen Zewinger ◽  
Marcus E. Kleber ◽  
Lucia Rohrer ◽  
Marlene Lehmann ◽  
Sarah Triem ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
High Density ◽  
High Density Lipoproteins ◽  
Symmetric Dimethylarginine
Sign in / Sign up

Export Citation Format

Share Document